|
Re: Todays FDA hearing on Avastin,news from Genentech..
"recommended that the FDA withdraw its approval of AvastinĀ® (bevacizumab) in combination with paclitaxel chemotherapy for previously untreated (first-line) HER2-negative metastatic breast cancer."
Does that mean that 2nd line etc are still in the mix?
|